Align Technology, Inc. (ALGN)
$
189.2
+1.15 (0.61%)
Key metrics
Financial statements
Free cash flow per share
8.2755
Market cap
13.6 Billion
Price to sales ratio
3.3644
Debt to equity
0.0204
Current ratio
1.3628
Income quality
3.0815
Average inventory
227.3 Million
ROE
0.1045
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Align Technology, Inc. is a prominent medical device company known for designing, manufacturing, and marketing Invisalign clear aligners and iTero intraoral scanners, along with related services tailored for orthodontists, general practitioner dentists, and professionals involved in restorative and aesthetic dentistry. The company earned an interest income of $16,045,000.00 showcasing its financial investments. Additionally, it incurred an income tax expense of $174,936,000.00 indicating its tax obligations. With an operating income ratio of 0.15 the firm demonstrates its operational profitability margins. The gross profit stands at $2,756,897,000.00 highlighting the company's profitability from core operations, while the weighted average number of diluted shares outstanding is 72,588,000.00 reflecting potential dilution effects. Operating through two main segments—the Clear Aligner segment, which provides a range of treatment options for teenagers and younger patients, and the Scanners and Services segment, which offers advanced scanning solutions—the company serves a wide market that includes the United States, Switzerland, China, and beyond. The stock is priced at $131.39 positioning it in the higher-end market, with an average trading volume of 1,195,081.00 indicating moderate liquidity. Holding a mid-range market capitalization of $13,575,100,000.00 Align Technology, Inc. is recognized as a steady performer in the medical technology field. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape and driving innovation and growth within the Healthcare sector. The diverse product offerings and reliable financial performance underscore Align Technology’s pivotal role in shaping the future of orthodontic and dental treatment solutions.
Is Align Technology, Inc. (ALGN) a good investment?
Investing in Align Technology, Inc. (ALGN) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.
What is Align Technology, Inc. (ALGN)'s stock forecast?
Analysts predict Align Technology, Inc. stock to fluctuate between $122 (low) and $208.31 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Align Technology, Inc.'s market capitalization?
As of 2026-02-27, Align Technology, Inc.'s market cap is $13,575,100,000, based on 71,750,000 outstanding shares.
How does Align Technology, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Align Technology, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Align Technology, Inc. (ALGN) stock?
To buy Align Technology, Inc. (ALGN) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ALGN. Place an order (Market, Limit, etc.).
What is the best time to invest in Align Technology, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Align Technology, Inc. perform in the last earnings report?
Revenue: $4,034,964,000 | EPS: $5.66 | Growth: 0.53%.
Where can I find Align Technology, Inc.'s investor relations reports?
Visit https://www.aligntech.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Align Technology, Inc.?
You can explore historical data from here
What is the all-time high and low for Align Technology, Inc. stock?
All-time high: $737.45 (2021-09-23) | All-time low: $122 (2025-09-25).
What are the key trends affecting Align Technology, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com
Here is how Align Technology (ALGN) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
seekingalpha.com
Align Technology delivered a second consecutive strong quarter, with Q4 results significantly exceeding both market and management expectations. ALGN remains undervalued, trading at a discount to sector and historical multiples, supporting a Buy rating and a raised target price of $195 (11% upside). Clear Aligner segment achieved record volumes, while Systems & Services growth and cost discipline drove margin expansion and robust profitability.
zacks.com
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
youtube.com
Align Technology president and CEO Joseph Hogan breaks down a strong earnings beat, driven by rising Invisalign demand among teenagers and accelerating growth in international markets on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #stocks #stockmarket #economy #markets #investing #wallstreet #finance #business #earnings #invisalign #health #globalpolitics
zacks.com
Align Technology (ALGN) came out with quarterly earnings of $3.29 per share, beating the Zacks Consensus Estimate of $2.99 per share. This compares to earnings of $2.44 per share a year ago.
businesswire.com
TEMPE, Ariz.--(BUSINESS WIRE)--Align is providing its iTero™ Lumina intraoral scanner, which will have a central role in the study's oral health data collection.
defenseworld.net
Wealth Enhancement Advisory Services LLC increased its stake in Align Technology, Inc. (NASDAQ: ALGN) by 38.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 15,551 shares of the medical equipment provider's stock after acquiring an additional 4,359 shares during the quarter. Wealth
zacks.com
After reaching an important support level, Align Technology, Inc. (ALGN) could be a good stock pick from a technical perspective. ALGN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
See all news
